RE:Price targets We've been seeing a series of minor target reductions and limited share volume recently and a cheap stock price.
My feeling is it's all related to cash being used in introducing SavvyWire. This is from the RBC report retiredcf posted
"Currently, only ~10% of US surgeons use LV pacing during TAVR procedures."
Educating surgeons to use new stuff can/ could be tricky but the adoption is tracking ahead of company expectations ; I'm pretty comfortable with RBC's $5 upper target , even Raymond James's $6 prediction.
Sometimes you're better off buying a stock with a 200% upside that it fails to reach than a 30% target that it does:)